Absolutely I think it's no coincidence the third program in Omnicar is for Gioblastoma. Could PTX include CLTX CAR in one of their programs or visa versa. It's about finding the best binding molecule and then controlling it perfectly with Omnicar. I suspect CLTX Car will be exactly that and as you say the duel intertumoral and standard infusion is unique to CHM. Then even attaching multiple targets with omnicar like a virus to help force an expression of the target. I hold both also and have been watching PTX closely for 6 months,managed a great entry. Bought more on Thursday and will be buying more in de-risk events. It is truly exciting times for holders and patients! Loving the commentary and research @dalts66
CHM Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)